Showing 81 - 100 results of 827 for search '"African trypanosomiasis"', query time: 0.72s Refine Results
  1. 81
  2. 82

    Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis. by Gerardo Priotto, François Chappuis, Mathieu Bastard, Laurence Flevaud, Jean-François Etard

    Published 2012-01-01
    “…BACKGROUND: Human African trypanosomiasis is fatal without treatment. The long post-treatment follow-up (24 months) required to assess cure complicates patient management and is a major obstacle in the development of new therapies. …”
    Get full text
    Article
  3. 83

    The structure of serum resistance-associated protein and its implications for human African trypanosomiasis by Zoll, S, Lane-Serff, H, Mehmood, S, Schneider, J, Robinson, CV, Carrington, M, Higgins, MK

    Published 2018
    “… <p>Only two trypanosome subspecies are able to cause human African trypanosomiasis. To establish an infection in human blood, they must overcome the innate immune system by resisting the toxic effects of trypanolytic factor 1 and trypanolytic factor 2. …”
    Journal article
  4. 84
  5. 85
  6. 86

    Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target? by Richard Selby, Charles Wamboga, Olema Erphas, Albert Mugenyi, Vincent Jamonneau, Charles Waiswa, Steve J Torr, Michael Lehane

    Published 2019-08-01
    “…In 1994, combined active and passive screening reported 1469 cases from the historic Gambian Human African Trypanosomiasis (gHAT) foci of West Nile, Uganda. …”
    Get full text
    Article
  7. 87
  8. 88
  9. 89

    The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases by Courtin Fabrice, Fèvre Eric M, Ruiz José A, Diarra Abdoulaye, Franco José R, Paone Massimo, Cecchi Giuliano, Simarro Pere P, Mattioli Raffaele C, Jannin Jean G

    Published 2010-11-01
    “…<p>Abstract</p> <p>Background</p> <p>Following World Health Assembly resolutions 50.36 in 1997 and 56.7 in 2003, the World Health Organization (WHO) committed itself to supporting human African trypanosomiasis (HAT)-endemic countries in their efforts to remove the disease as a public health problem. …”
    Get full text
    Article
  10. 90
  11. 91

    Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis by Santo Previti, Roberta Ettari, Carla Di Chio, Rahul Ravichandran, Marta Bogacz, Ute A. Hellmich, Tanja Schirmeister, Sandro Cosconati, Maria Zappalà

    Published 2022-06-01
    “…Human African Trypanosomiasis (HAT) is an endemic protozoan disease widespread in the sub-Saharan region that is caused by <i>T. b. gambiense</i> and <i>T. b. rhodesiense</i>. …”
    Get full text
    Article
  12. 92
  13. 93

    Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea. by Alseny M'mah Soumah, Mariame Camara, Justin Windingoudi Kaboré, Ibrahim Sadissou, Hamidou Ilboudo, Christelle Travaillé, Oumou Camara, Magali Tichit, Jacques Kaboré, Salimatou Boiro, Aline Crouzols, Jean Marc Tsagmo Ngoune, David Hardy, Aïssata Camara, Vincent Jamonneau, Annette MacLeod, Jean-Mathieu Bart, Mamadou Camara, Bruno Bucheton, Brice Rotureau

    Published 2024-08-01
    “…The skin is an anatomical reservoir for African trypanosomes, yet the prevalence of extravascular parasite carriage in the population at risk of gambiense Human African Trypanosomiasis (gHAT) remains unclear. Here, we conducted a prospective observational cohort study in the HAT foci of Forecariah and Boffa, Republic of Guinea. …”
    Get full text
    Article
  14. 94

    Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda. by Finola Hackett, Lea Berrang Ford, Eric Fèvre, Pere Simarro

    Published 2014-02-01
    “…We mapped spatial variation in the burden of human African trypanosomiasis (HAT) in Uganda for the years 2000-2009. …”
    Get full text
    Article
  15. 95

    Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense. by Lorna M MacLean, Martin Odiit, John E Chisi, Peter G E Kennedy, Jeremy M Sternberg

    Published 2010-12-01
    “…Diverse clinical features have been reported in human African trypanosomiasis (HAT) foci caused by Trypanosoma brucei rhodesiense (T.b.rhodesiense) giving rise to the hypothesis that HAT manifests as a chronic disease in South-East African countries and increased in virulence towards the North. …”
    Get full text
    Article
  16. 96

    Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo. by Ronald E Crump, Ching-I Huang, Edward S Knock, Simon E F Spencer, Paul E Brown, Erick Mwamba Miaka, Chansy Shampa, Matt J Keeling, Kat S Rock

    Published 2021-01-01
    “…Gambiense human African trypanosomiasis (gHAT) is a virulent disease declining in burden but still endemic in West and Central Africa. …”
    Get full text
    Article
  17. 97
  18. 98

    Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis by Maxwell Waema, Naomi Maina, Simon Karanja, Beatrice Gachie, Maina Ngotho, John Kagira

    Published 2014-10-01
    “…Identifying an animal model of T. b. brucei that mimics human African trypanosomiasis (HAT) would enable researchers to study HAT without subjecting themselves to undue risks such as accidental infection. …”
    Get full text
    Article
  19. 99

    Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. by Jean Rodgers, Amy Jones, Stéphane Gibaud, Barbara Bradley, Christopher McCabe, Michael P Barrett, George Gettinby, Peter G E Kennedy

    Published 2011-09-01
    “…Human African trypanosomiasis (HAT), or sleeping sickness, results from infection with the protozoan parasites Trypanosoma brucei (T. b.) gambiense or T. b. rhodesiense and is invariably fatal if untreated. …”
    Get full text
    Article
  20. 100

    The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis. by Andrew P Jackson, Mandy Sanders, Andrew Berry, Jacqueline McQuillan, Martin A Aslett, Michael A Quail, Bridget Chukualim, Paul Capewell, Annette MacLeod, Sara E Melville, Wendy Gibson, J David Barry, Matthew Berriman, Christiane Hertz-Fowler

    Published 2010-04-01
    “…Trypanosoma brucei gambiense is the causative agent of chronic Human African Trypanosomiasis or sleeping sickness, a disease endemic across often poor and rural areas of Western and Central Africa. …”
    Get full text
    Article